TLR12P: A Potential Drug Target and Biomarker (G100131451)

Target Name: TLR12P

NCBI ID: G100131451

TLR12P

Other Name(s): Toll-like receptor 12, pseudogene | toll like receptor 12, pseudogene

TLR12P: A Potential Drug Target and Biomarker

TLR12P, also known as TLR12, is a protein that is expressed in many different tissues and cells in the body. It is a key regulator of the innate immune response, which is the body's first line of defense against infections and other harmful substances. TLR12P plays a crucial role in the regulation of inflammation, cell death, and survival.

The TLR12P protein is composed of several subunits that are held together by disulfide bonds. These subunits include a catalytic subunit, a regulatory subunit, and a transmembrane subunit. The catalytic subunit consists of a critical region that is involved in the catalytic activity of TLR12P. This region contains a catalytic active site that is optimized for the production of reactive oxygen species (ROS), which are highly reactive molecules that can cause damage to cells and contribute to the development of various diseases.

TLR12P is expressed in many different tissues and cells, including macrophages, dendritic cells, and epithelial cells. It is involved in the regulation of a wide range of cellular processes, including inflammation, cell death, and survival. It is also involved in the regulation of cellular signaling pathways, including the TGF-β pathway and the NF-kappa-B pathway.

TLR12P has been identified as a potential drug target due to its involvement in the regulation of inflammation and cellular signaling pathways. It is thought to be involved in the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In addition to its potential as a drug target, TLR12P is also a potential biomarker for certain diseases. Its involvement in the regulation of inflammation and cellular signaling pathways makes it a promising candidate for use as a diagnostic marker for a wide range of diseases. For example, TLR12P may be used as a biomarker for cancer, as it has been shown to be involved in the regulation of cellular signaling pathways that are commonly observed in cancer cells.

TLR12P is also a potential biomarker for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles, which are thought to be caused by the buildup of toxic substances in the brain. TLR12P is involved in the regulation of cellular signaling pathways that are thought to be involved in the development and progression of these conditions, making it a promising candidate as a biomarker for these diseases.

TLR12P is also a potential biomarker for autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. These conditions are characterized by the immune system attacking the body's own tissues, leading to inflammation and damage. TLR12P is involved in the regulation of cellular signaling pathways that are thought to be involved in the development and progression of these conditions, making it a promising candidate as a biomarker for these diseases.

In conclusion, TLR12P is a protein that is involved in the regulation of the innate immune response and has been identified as a potential drug target and biomarker for a wide range of diseases. Its catalytic active site, which is optimized for the production of reactive oxygen species, makes it a promising candidate as a drug target for diseases that are characterized by inflammation and cellular stress. Further research is needed to fully understand the role of TLR12P in the regulation of inflammation and cellular signaling pathways, and to determine its potential as a drug target and biomarker.

Protein Name: Toll Like Receptor 12, Pseudogene

The "TLR12P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TLR12P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets